Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2017, Article ID 6827384, 4 pages
https://doi.org/10.1155/2017/6827384
Research Article

Trends in the Incidence of Cervical Cancer in Jordan, 2000–2013

1Field Epidemiology Training Program, Non-Communicable Diseases, Ministry of Health, Amman, Jordan
2Jordan Cancer Registry, Ministry of Health, Amman, Jordan
3Department of Public Health, Jordan University of Science & Technology, Irbid, Jordan
4Jordan University, Amman, Jordan
5Department of Nutrition, Royal Medical Services, Amman, Jordan
6Department of Family Medicine, Ministry of Health, Amman, Jordan

Correspondence should be addressed to Ghazi Sharkas; moc.oohay@sakrahsizahg

Received 28 January 2017; Revised 14 July 2017; Accepted 30 July 2017; Published 27 August 2017

Academic Editor: Akira Hara

Copyright © 2017 Ghazi Sharkas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  2. Cervical cancer estimated incidence, mortality and prevalence worldwide in 2012.
  3. H. Sancho-Garnier, Y. C. Khazraji, M. H. Cherif et al., “Overview of cervical cancer screening practices in the extended middle east and North Africa Countries,” Vaccine, vol. 31, no. 6, pp. G51–G57, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. L. S. Freedman, B. K. Edwards, L. A. G. Ries, and J. L. Young, Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER, National Cancer Institute, Bethesda, MD.
  5. R. Sankaranarayanan, A. M. Budukh, and R. Rajkumar, “Effective screening programmes for cervical cancer in low- and middle-income developing countries,” in Bull World Health Organ, vol. 79, pp. 954–962, 10 edition, 2001. View at Google Scholar
  6. S. Vaccarella, J. Lortet-Tieulent, M. Plummer, S. Franceschi, and F. Bray, “Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors,” European Journal of Cancer, vol. 49, no. 15, pp. 3262–3273, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Arbyn, X. Castellsagué, S. de sanjosé et al., “Worldwide burden of cervical cancer in 2008,” Annals of Oncology, vol. 22, no. 12, pp. 2675–2686, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Adegoke, S. Kulasingam, and B. Virnig, “Cervical cancer trends in the United States: a 35-year population-based analysis,” Journal of Women's Health, vol. 21, no. 10, pp. 1031–1037, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. A. Dickinson, A. Stankiewicz, C. Popadiuk, L. Pogany, J. Onysko, and A. B. Miller, “Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006,” BMC Public Health, vol. 12, p. 992, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Mosavi-Jarrahi and E. V. Kliewer, “Cervical cancer incidence trends in Canada: a 30-year population-based analysis,” Journal of Obstetrics and Gynaecology Canada, vol. 35, no. 7, pp. 620–626, 2013. View at Publisher · View at Google Scholar
  11. World Health Organization, Regional Office for the Eastern Mediterranean. Towards a strategy for cancer control in the Eastern Mediterranean Region, 2009.
  12. J. Sherris, C. Herdman, and C. Elias, “Cervical cancer in the developing world,” Western Journal of Medicine, vol. 175, no. 4, pp. 231–233, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Bruni, M. Diaz, X. Castellsagué, E. Ferrer, F. X. Bosch, and S. De Sanjosé, “Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings,” Journal of Infectious Diseases, vol. 202, no. 12, pp. 1789–1799, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Formana, C. de Martel, C. J. Lacey et al., “Global burden of human papillomavirus and related diseases,” Vaccine, vol. 30, supplement 5, pp. F12–F23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. ICO Information Centre on HPV and Cancer, Human papillomavirus and related cancers, Fact Sheet 2017.
  16. M. Arab and G. Noghabaei, “Comparison of age standard incidence rate trends of gynecologic and breast cancer in Iran and other countries,” Iran J Public Health, vol. 43, no. 10, pp. 1372–1379, 2014. View at Google Scholar
  17. Global Burden of Disease Cancer Collaboration, “The Global Burden of Cancer 2013,” JAMA Oncol, vol. 1, no. 4, pp. 505–507, 2015. View at Google Scholar
  18. P. Badrinath, S. Ghazal-Aswad, N. Osman, E. Deemas, and S. McIlvenny, “A study of knowledge, attitude, and practice of cervical screening among female primary care physicians in the United Arab Emirates,” Health Care for Women International, vol. 25, no. 7, pp. 663–670, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Al Nsour, D. W. Brown, M. Tarawneh, R. Haddadin, and H. Walk, “Breast and cervical cancer screening among women in Jordan: findings from the behavioural risk factor surveillance system - 2007,” Open Breast Cancer Journal, vol. 4, pp. 1–7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Maaita and M. Barakat, “Jordanian women's attitudes towards cervical screening and cervical cancer,” Journal of Obstetrics and Gynaecology, vol. 22, no. 4, pp. 421-422, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. F. J. Altaf, “Cervical cancer screening with pattern of pap smear: Review of multicenter studies,” Saudi Medical Journal, vol. 27, no. 10, pp. 1498–1502, 2006. View at Google Scholar · View at Scopus